Charles Theuer - Feb 1, 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
President and CEO, Director
Signature
/s/ Scott B. Brown (Attorney-in-Fact)
Stock symbol
TCON
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 06:55 PM
Previous filing
Jan 19, 2023
Next filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Employee Stock Option (Right to Buy) Award $0 +332K $0.00 332K Feb 1, 2023 Common Stock 332K $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.